Stock THC THC BIOMED INTL LTD.
Add to a list
To use this feature you must be a member
Log inSign up

THC Biomed Intl Ltd. Stock

Equities

THC

CA87243W1032

Pharmaceuticals

Market Closed - Canadian Securities Exchange
Other stock markets
 12:55:44 2024-01-31 pm EST 		5-day change 1st Jan Change
0.02 CAD -.--% Intraday chart for THC Biomed Intl Ltd. -.--% -.--%
2023 THC Biomed Intl Ltd. Introduces Always Hi New Brand Catering to Maturing Cannabis Consumer Trends CI
2023 Thc Biomed Intl Ltd. Launches New Summer Cannabis Product: Thc Kiss Strawberry Tangerine Gummies CI

Financials

Sales 2021 2.63M 1.91M Sales 2022 2.45M 1.78M Capitalization 7.38M 5.36M
Net income 2021 -6M -4.36M Net income 2022 -3M -2.18M EV / Sales 2021 8.24 x
Net Debt 2021 4.46M 3.24M Net Debt 2022 4M 2.91M EV / Sales 2022 4.65 x
P/E ratio 2021
-2.7 x
P/E ratio 2022
-2.41 x
Employees 35
Yield 2021 *
-
Yield 2022
-
Free-Float 68.87%
More Fundamentals * Assessed data

Chart THC Biomed Intl Ltd.

Dynamic Chart

Latest news about THC Biomed Intl Ltd.

THC Biomed Intl Ltd. Introduces Always Hi New Brand Catering to Maturing Cannabis Consumer Trends CI
Thc Biomed Intl Ltd. Launches New Summer Cannabis Product: Thc Kiss Strawberry Tangerine Gummies CI
THC Biomed Intl Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023 CI
THC Biomed Intl Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023 CI
THC Biomed Intl Ltd. acquired 40% stake in THC BioMed Co. Ltd for $0.06 million. CI
THC Biomed Intl Ltd. to Open First Medical Cannabis Dispensary in Asia CI
THC Biomed Intl Ltd. Announces CBD KISS Mango Beverage Shot and CBD Biscuits Begin sales in Ontario CI
THC Biomed Intl Ltd. Reports Earnings Results for the First Quarter Ended October 31, 2022 CI
THC Biomed Intl Ltd. Auditor Raises 'Going Concern' Doubt CI
THC Biomed Intl Ltd. Reports Earnings Results for the Full Year Ended July 31, 2022 CI
THC Biomed Intl Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022 CI
THC Biomed Intl Ltd. Announces Broker and Commercial Sales Agreement with World Wide Brands Limited CI
THC Biomed Intl Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022 CI
THC BioMed Intl Ltd. Announces Availability of THC KISS Cannabis Biscuits to Consumers Through Ontario Cannabis Store Online and Wholesale to Ontario Retail Stores CI
THC Biomed Intl Ltd. Grants Licence by Overseas Government to Cultivate Cannabis for Medical and Scientific Use CI
More news

Press releases THC Biomed Intl Ltd.

Canadian Investment Regulatory Organization Trading Halt - THC AQ
THC BioMed Intl : Secures $425,000 Loan PU
THC BioMed Intl : Announces Strategic Operational Restructuring, Targets Micro-Producers PU
THC Biomed Intl : Commences Service Within New BC Direct Delivery Program PU
THC Biomed Intl : Interim Financial Report PU
More press releases

Highs and lows

Current year
0.01
Extreme 0.01
0.03
1 year
0.01
Extreme 0.01
0.05
3 years
0.01
Extreme 0.01
0.16
5 years
0.01
Extreme 0.01
0.34
10 years
0.01
Extreme 0.01
3.36
More quotes

Managers and Directors - THC Biomed Intl Ltd.

Managers TitleAgeSince
John Miller CEO
 Chief Executive Officer 57 15-01-13
Hee Jung Chun DFI
 Director of Finance/CFO 48 15-01-13
Members of the board TitleAgeSince
Hee Jung Chun DFI
 Director of Finance/CFO 48 15-01-13
John Miller CEO
 Chief Executive Officer 57 15-01-13
Ashish Dave BRD
 Director/Board Member - 17-06-12
More insiders

Company Profile

THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho).
Sector
Pharmaceuticals
Calendar
2024-06-26 - Q3 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
THC BIOMED INTL LTD. Stock THC Biomed Intl Ltd.
-.--% 2.38M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+40.86% 6.16B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-16.30% 4.49B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.93% 3.17B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
-1.58% 3.01B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-1.70% 2.57B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+37.23% 1.8B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-12.78% 1.62B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+1.02% 1.56B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.97% 1.53B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. THC Stock